glp-1 alternatives Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Compounded GLP-1 medications are trending

Cell, 153(6), 11941217

Cox DJ, Kovatchev BP, Gonder-Frederick LA, Summers KH, McCall A, Grimm KJ, et al

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice

The SURMOUNT-1 trial showed approximately 20.9% average body weight reduction at 72 weeks under controlled conditions with the highest dose of FDA-approved tirzepatide

Our latest article, written in partnership with AULV Health, explores why metabolic dysfunction may become one of the biggest opportunities in #cannabinoid medicine

Medullary thyroid cancer makes up maybe 3% of all thyroid cancers, so it's a very small proportion, but that's the one you see the warnings about in the commercials